Analysen zu Hermès (Hermes International)
| 25.10.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 24.10.24 | Hermès Buy | UBS AG | |
| 24.10.24 | Hermès Hold | Deutsche Bank AG | |
| 24.10.24 | Hermès Buy | Jefferies & Company Inc. | |
| 07.10.24 | Hermès Buy | Jefferies & Company Inc. | |
| 07.10.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 02.10.24 | Hermès Hold | Deutsche Bank AG | |
| 24.09.24 | Hermès Buy | UBS AG | |
| 20.09.24 | Hermès Buy | Jefferies & Company Inc. | |
| 20.09.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 10.09.24 | Hermès Outperform | Bernstein Research | |
| 09.09.24 | Hermès Overweight | Barclays Capital | |
| 20.08.24 | Hermès Outperform | Bernstein Research | |
| 02.08.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 30.07.24 | Hermès Overweight | Barclays Capital | |
| 29.07.24 | Hermès Buy | UBS AG | |
| 26.07.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 26.07.24 | Hermès Buy | UBS AG | |
| 15.07.24 | Hermès Buy | UBS AG | |
| 05.07.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 04.07.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 04.07.24 | Hermès Buy | UBS AG | |
| 04.07.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 27.06.24 | Hermès Buy | UBS AG | |
| 19.06.24 | Hermès Outperform | Bernstein Research | |
| 31.05.24 | Hermès Hold | Deutsche Bank AG | |
| 28.05.24 | Hermès Outperform | Bernstein Research | |
| 20.05.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 26.04.24 | Hermès Hold | Deutsche Bank AG | |
| 26.04.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 25.04.24 | Hermès Halten | DZ BANK | |
| 25.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 25.04.24 | Hermès Buy | UBS AG | |
| 25.04.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 11.04.24 | Hermès Overweight | Barclays Capital | |
| 10.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 09.04.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 02.04.24 | Hermès Buy | UBS AG | |
| 08.03.24 | Hermès Buy | UBS AG | |
| 01.03.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 29.02.24 | Hermès Overweight | Barclays Capital | |
| 13.02.24 | Hermès Halten | DZ BANK | |
| 12.02.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | Hermès Neutral | Goldman Sachs Group Inc. | |
| 12.02.24 | Hermès Buy | UBS AG | |
| 09.02.24 | Hermès Buy | UBS AG | |
| 09.02.24 | Hermès Market-Perform | Bernstein Research | |
| 09.02.24 | Hermès Neutral | JP Morgan Chase & Co. | |
| 07.02.24 | Hermès Overweight | Morgan Stanley | |
| 19.01.24 | Hermès Buy | UBS AG |
Aktuelle Aktienanalysen
| 17.12.25 | Diageo Neutral | JP Morgan Chase & Co. | |
| 17.12.25 | Pernod Ricard Neutral | JP Morgan Chase & Co. | |
| 17.12.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 17.12.25 | Kering Underweight | JP Morgan Chase & Co. | |
| 17.12.25 | Münchener Rückversicherungs-Gesellschaft Neutral | UBS AG | |
| 17.12.25 | Zurich Insurance Sell | UBS AG | |
| 17.12.25 | Hannover Rück Buy | UBS AG | |
| 17.12.25 | AXA Buy | UBS AG | |
| 17.12.25 | Allianz Neutral | UBS AG | |
| 17.12.25 | DocMorris Sell | UBS AG | |
| 17.12.25 | Redcare Pharmacy Neutral | UBS AG | |
| 17.12.25 | VINCI Buy | UBS AG | |
| 17.12.25 | IONOS Buy | Goldman Sachs Group Inc. | |
| 17.12.25 | Vienna Insurance kaufen | Erste Group Bank | |
| 17.12.25 | Beiersdorf Sell | UBS AG | |
| 17.12.25 | Sartorius vz. Buy | Deutsche Bank AG | |
| 17.12.25 | IONOS Overweight | JP Morgan Chase & Co. | |
| 17.12.25 | Carl Zeiss Meditec Buy | Goldman Sachs Group Inc. | |
| 17.12.25 | Pernod Ricard Hold | Deutsche Bank AG | |
| 17.12.25 | Nemetschek Hold | Deutsche Bank AG | |
| 17.12.25 | Akzo Nobel Buy | Goldman Sachs Group Inc. | |
| 17.12.25 | ABB Sector Perform | RBC Capital Markets | |
| 17.12.25 | thyssenkrupp nucera Outperform | RBC Capital Markets | |
| 17.12.25 | Südzucker Hold | Deutsche Bank AG | |
| 17.12.25 | ASML NV Equal Weight | Barclays Capital | |
| 17.12.25 | Rio Tinto Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.12.25 | Netflix Buy | Jefferies & Company Inc. | |
| 17.12.25 | Hapag-Lloyd Hold | Deutsche Bank AG | |
| 17.12.25 | Pernod Ricard Buy | Jefferies & Company Inc. | |
| 17.12.25 | BASF Buy | Goldman Sachs Group Inc. | |
| 17.12.25 | Philips Overweight | Barclays Capital | |
| 17.12.25 | Swiss Re Neutral | UBS AG | |
| 17.12.25 | Assicurazioni Generali Buy | UBS AG | |
| 17.12.25 | Philips Sector Perform | RBC Capital Markets | |
| 17.12.25 | Siemens Healthineers Outperform | RBC Capital Markets | |
| 17.12.25 | Beiersdorf Hold | Jefferies & Company Inc. | |
| 16.12.25 | Philips Market-Perform | Bernstein Research | |
| 16.12.25 | Sartorius vz. Outperform | Bernstein Research | |
| 16.12.25 | VINCI Buy | Jefferies & Company Inc. | |
| 16.12.25 | Sartorius Stedim Biotech Outperform | Bernstein Research | |
| 16.12.25 | Carl Zeiss Meditec Outperform | Bernstein Research | |
| 16.12.25 | Gerresheimer Underperform | Bernstein Research | |
| 16.12.25 | Siemens Healthineers Outperform | Bernstein Research | |
| 16.12.25 | Pfizer Buy | Jefferies & Company Inc. | |
| 16.12.25 | BMW Overweight | JP Morgan Chase & Co. | |
| 16.12.25 | arGEN-X Outperform | Bernstein Research | |
| 16.12.25 | UBS Kaufen | DZ BANK | |
| 16.12.25 | Pfizer Neutral | JP Morgan Chase & Co. | |
| 16.12.25 | Volvo AB Buy | UBS AG | |
| 16.12.25 | Schneider Electric Buy | UBS AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.